New shot shields High-Risk infants from RSV
NCT ID NCT06710925
First seen Mar 11, 2026 · Last updated May 23, 2026 · Updated 12 times
Summary
This study tested a new medicine called TNM001 to see if it can prevent serious lung infections caused by RSV in high-risk babies under 1 year old. About 315 infants received either the medicine or a placebo and were followed for 9 months. The goal was to see if the antibody could safely reduce RSV-related lung infections.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS INFECTIONS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Children's Hospital of Chongqing Medical University
Chongqing, Sichuan, 404100, China
-
West China Second University Hospital, Sichuan University
Chengdu, Sichuan, 610000, China
Conditions
Explore the condition pages connected to this study.